<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-BDI-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Burundi (le): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Burundi: Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">Captiva Africa LLC</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-44001" role="4" type="40">
   <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Burundi</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="BI" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="BI" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Bujumbura</narrative>
   </name>
   <administrative code="BI" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>-3.3822 29.3644</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1201987</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1606888</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">942720</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">74067.33</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">74067.33</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="BDIPEF-TCA-CAPTIVA2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">55944</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CAPTIVA (Captiva Africa LLC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Captiva Africa LLC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-CDC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">40500</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-JSI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">6809</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-STI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">106254</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-STI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">8594</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">466236</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">517650</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-CAPTIVA2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CAPTIVA (Captiva Africa LLC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Captiva Africa LLC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-IBRD2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">200000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-JSI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">11480</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">39714</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">652212</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">703482</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-IBRD2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">100000</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-JSI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">11480</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">69176</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">386395</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="BDIPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">375670</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001027">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">55944</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CAPTIVA (Captiva Africa LLC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Captiva Africa LLC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000917">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">40500</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">-5430</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-DALBERG (Dalberg Consulting CC)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">Dalberg Consulting CC</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001342">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-06"></transaction-date>
   <value currency="USD" value-date="2020-04-06">200000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002781">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-17"></transaction-date>
   <value currency="USD" value-date="2021-06-17">100000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">6809</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001061">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">69175</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-STI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900001228">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">-21208</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-STI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900001356">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-55258</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-STI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900006992">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">49903</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-STI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000749">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-05"></transaction-date>
   <value currency="USD" value-date="2019-12-05">8490</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-STI</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">7604</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-513</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">15714</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-21176</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">21176</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">1163</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">5425</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">2250</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000918">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">466236</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">466236</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">185976</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002681">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">386395</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000919">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">517650</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">517623</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">185859</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002722">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">375670</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-burundi-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Burundi 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-burundi-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Burundi 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-burundi-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Burundi 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-burundi-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Burundi 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-burundi-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Burundi 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-burundi-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Burundi 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-burundi-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Burundi 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-burundi-2010">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance plan Burundi 2010</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-22"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-burundi-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Burundi 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-05-31"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-BDI" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">KAP study conducted at national level</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Conduction of KAP studies and anthropological research on routine immunisation">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">* TOR for the recruitment of CAP consultant being finalized 
*Roadmap established</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Master training on IPC is implemented with 188 FLW trained</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the country?s immunization program to conduct IPC and community engagement trainings for FLW">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">TOR for the recruitment of IPC consultant being finalized</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Human Centered Design Master trainers is implemented for 50 focal points of 47 districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Master training-Capacity development in demand promotion-Human centered design">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Technical preparation meetings with the communication unit of the Expanded Immunization Program organized</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The CAP survey has been done and the report finalized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the EPI for the completion of the CAP survey">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">* TOR for the recruitment of CAP consultant being finalized *Roadmap established; 
Recruitment process to be launch on December 2021 and, data collection to begin in January</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the EPI for the completion of the CAP survey">
      <location ref="BI"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The activity was delayed due to Covid-19. Funds fr this activity was reallocated to covid-19 response. The activity is planned in the second semester of 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the EPI for the completion of the CAP survey">
      <location ref="BI"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The activity was delayed due to Covid-19. Funds fr this activity was reallocated to covid-19 response. The activity is planned in the second semester of 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 98 % of all installed SDD refrigerator are working</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MoH/ PEV for post installation follow up and monitoring of solar refrigerators newly installed">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">99% (789/797)of SDD refrigerator from health districts and health centers are working.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MoH/ PEV for post installation follow up and monitoring of solar refrigerators newly installed">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">99% (789/797)of SDD refrigerator from health districts and health centers are working.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 80% of all districts have good score (based on national check list) in waste management</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MoH/ EPI to strengthen the management of vaccine waste at all levels">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">At the national level, a contract was concluded between the EPI and a local Institution (INSP) for the waste management (destruction) from vaccines delivery. At the operational level (health district and health center), waste management has been taken into account in the new SPOs for logistic and vaccine management and cascade training on these new SPOs has been started by health district staff (vaccine managers and EPI Focal points). The training will be continued in the next quarter to train health center staff on the new SOPs. The evaluation of waste management at all levels will be conducted early in July with EVM.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MoH/ EPI to strengthen the management of vaccine waste at all levels">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">At the national level, a contract was concluded between the EPI and a local Institution (INSP) for the waste management (destruction) from vaccines delivery. At the operational level (health district and health center), waste management has been taken into account in the new SPOs for logistic and vaccine management and cascade training on these new SPOs has been started by health district staff (vaccine managers and EPI Focal points). The training will be continued in the next quarter to train health center staff on the new SOPs. The evaluation of waste management at all levels will be conducted early in July with EVM.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 90% of health district has no reported stock out issues</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MoH/ EPI to build capacity of EPI staff at all levels on the vaccines and logistics tools (EPILOG, Forecast, SMT)">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Staff from national and district levels have been trained. At 98% of health district has reported zero stock out for vaccines and injection devices.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MoH/ EPI to build capacity of EPI staff at all levels on the vaccines and logistics tools (EPILOG, Forecast, SMT)">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Staff from national and district levels have been trained. At 98% of health district has reported zero stock out for vaccines and injection devices.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of the construction work is already done: The rehabilitation /construction of offices and stocks of 3 Health Districts has been finalized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the rehabilitation/construction of offices and stocks of EPI and Health Districts">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The construction of offices and stocks of 2 health districts is finalized. The provisional acceptance of the works took place in May 2021. The construction of the 3rd district will be finalized soon, its reception is scheduled for July 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the rehabilitation/construction of offices and stocks of EPI and Health Districts">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The construction of offices and stocks of 2 health districts is finalized. The provisional acceptance of the works took place in May 2021. The construction of the 3rd district will be finalized soon, its reception is scheduled for July 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 80% of districts have implemented continuous monitoring system of temperature of the cold chain equipment</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MoH/ PEV for installation of continuous monitoring system of temperature of the cold chain equipment at central and district levels">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Funds to purchase the devices are not yet available. However, a pilot phase in 25 storage sites (16 health centers, 8 HD and at central level) will be carried out in December 2021. Th training will start on 29th November 2021, follow with the installation of the devices in different sites</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MoH/ PEV for installation of continuous monitoring system of temperature of the cold chain equipment at central and district levels">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">This activity is delayed due to lack of funds to purchase the equipment of continuous monitoring system. The acquisition of this equipment is scheduled for the second semester of 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MoH/ PEV for installation of continuous monitoring system of temperature of the cold chain equipment at central and district levels">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">This activity is delayed due to lack of funds to purchase the equipment of continuous monitoring system. The acquisition of this equipment is scheduled for the second semester of 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least two modules are integrated in DHIS2</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen national capacities on DHIS2 Management at all levels and initiate the interoperability with other existing databases by involving the partnership between GAVI Alliance and the University of Oslo">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Administrators training had been conducted in April/May ; now the work to integrate RapidSMS and iCCM inputs Management applications is in on progress.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen national capacities on DHIS2 Management at all levels and initiate the interoperability with other existing databases by involving the partnership between GAVI Alliance and the University of Oslo">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Administrators training had been conducted in April/May ; now the work to integrate RapidSMS and iCCM inputs Management applications is in on progress.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least two capacity building workshops conducted at sub-national level, and initial BNA indicators validated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthening of national health information system (HIS),&#xA0; through better quality and use of immunisation data - through BNA, Action Tracker &amp; Scorecards applications for DHIS2">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">An joint evaluation followed by updating pro-equity micro-plans was carried out for 18 DS in 2020. In 2021, an BNA analysis and indicators validation are programmed for the 2021 third quarter in preparation for the DHIS2 BNA application</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least two nationl workshops and 3 decetralised workshops organised to implement the pilot phase of electronic register</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MoH (DSNIS &amp; PEV) to establish an electronic register for vaccination">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Due to Covid-19 the activity was delayed but now, with UNICEF support, the EPI prepare the readiness assessment which is planned for the third quarter of this year 2021 with support from RO. Next step will be to implement a pilot project of electronic register in some health districts.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MoH (DSNIS &amp; PEV) to establish an electronic register for vaccination">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Due to Covid-19 the activity was delayed but now, with UNICEF support, the EPI prepare the readiness assessment which is planned for the third quarter of this year 2021 with support from RO. Next step will be to implement a pilot project of electronic register in some health districts.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MoH (DSNIS &amp; PEV) to establish an electronic register for vaccination">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The activity is postponed for the 1st semester of 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least&#xA0;2 pilote health districts using the BNA, Action Tracker &amp; Scorecards applications for DHIS2 during their quarterly reviews</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthening of national health information system (HIS),&#xA0; through better quality and use of immunisation data - through BNA, Action Tracker &amp; Scorecards applications for DHIS2">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Due to covid-19, the activity is delayed. The BNA application is not yet installed. With the support with RO, an implementation plan is set to install an BNA and action tracker app on DHIS2 for the third and fourth quarter .</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthening of national health information system (HIS),&#xA0; through better quality and use of immunisation data - through BNA, Action Tracker &amp; Scorecards applications for DHIS2">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Due to covid-19, the activity is delayed. The BNA application is not yet installed. With the support with RO, an implementation plan is set to install an BNA and action tracker app on DHIS2 for the third and fourth quarter .</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthening of national health information system (HIS),&#xA0; through better quality and use of immunisation data - through BNA, Action Tracker &amp; Scorecards applications for DHIS2">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">We prepare a workshop to identify tracer interventions and their indicators for which bottlenecks will be analyzed using DHIS2 data. Afterwards, application configuration will be made in the DHIS2 and the bottleneck analysis will follow</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 80% of health districts have updated their pro-equity micro-plans</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support microplanning of immunization activities at the district level to improve coverage and equity">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Due to a lack of funds for this activity, only 18 DS out of 47 (38%) have updated their pro-equity micro-plans.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">An urban strategy to increase the performance in immunization is available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MoH/ EPI for the elaboration of an urban strategy to increase the performance in immunization of Health Districts in Bujumbura City and other urban centers">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The ToR for the activity have been developped and share with the MoH . 
The activity is late for two reasons:
- Difficulty for resources mobilizing for operational costs (Situation analysis workshop with all stakeholders; strategy appropriation workshop which will be developed with the international consultant support)
-Availability of the international consultant in the context of Covid-19.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A joint evaluation of second-generation pro-equity micro-plans has been completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support microplanning of immunization activities at the district level to improve coverage and equity">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The 18 priority HD have reviewed and updated their pro-equity micro-plans. With support from Gavi HSS3 , the implementation of pro-equity micro-plans are ongoing. The review of their micro-plans will be conducted in the first semester of 2022. Support was give also for the development of micro-plans in 31 other health districts that did not have one</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support microplanning of immunization activities at the district level to improve coverage and equity">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The activity was postponed due to lack of funds for operational costs. This activity will take place in the second semester 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support microplanning of immunization activities at the district level to improve coverage and equity">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The activity was postponed due to lack of funds for operational costs. This activity will take place in the second semester 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least one health district in Bujumbura city implement the urban strategy to increase coverage and equity</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MoH/ EPI for implementation of urban strategy to increase the performance and equity in immunization of Health Districts in Bujumbura City">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Due to the Covid-19 context, the avaibility of a international consultant still a challenge to complete this activity.
ToR have been developed and republished, the recruitment process is underway.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The plan for maintaining maternal and noenatal tetanus elimination status is updated.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the EPI in the planning, implementaion, coordination, monitoring and evaluation of immunization activities (RED and microplans implementation, organization of coordination meetings, GTSME meetings, staff training, supervisions, development of the annual action plan, updating of strategic documents: Maintenance plan, guide technique du PEV, MNT elimination status, national measles and rubella elimination strategy)">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Due to the unavailability of funds, the plan for maintaining MNT elimination is not yet updated. The activity has been postponed to the first semester of 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EPI Annual workplan 2021-2022 and budgets including interventions to reach zero dose children in place</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the EPI in the planning, implementaion, coordination, monitoring and evaluation of immunization activities (RED and microplans implementation, organization of coordination meetings, GTSME meetings, staff training, supervisions, development of the annual action plan, updating of strategic documents: Maintenance plan, guide technique du PEV, MNT elimination status, national measles and rubella elimination strategy)">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF give support to the EPI to prepare and finalize its Annual Working 2021-2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) At least 90% of Health districts have perfomance indicators of AFP and measles in the norms

2) 1 global feedback bulletin on the 47 DS is produced each month. In total 12 bulletins producted annualy</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support surveillance of vaccine-preventable diseases ( AFP, measles, maternal neonatal tetanus, congenital rubella, meningitis, diarrhea rotavirus ...)">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">2 supervisions int&#xE9;gr&#xE9;es ont &#xE9;t&#xE9; r&#xE9;alis&#xE9;es au cours de l ann&#xE9;e 2020 -2021 et ont montr&#xE9; des progr&#xE8;s significatifs dans la surveillance des MEV. L &#xE9;valuation des donn&#xE9;es a montr&#xE9; que les indicateurs de suivi de la surveillance de la rougeole sont de 15, 58 et le taux d &#xE9;ruption non rougeoleuse est de 3, 23 et pour la surveillance des PFA, la proportion de districts ayant atteint les 2 indicateurs de performance (le taux de PFA non polio =2/100000 et une proportion sup &#xE0; 80% d?&#xE9;chantillons ad&#xE9;quats) : 17,02% (8 DS/47)
Taux d?ent&#xE9;rovirus non polio : 7,9% (seuil : &gt;=10%)
et Taux de PFA non Polio = 2,11 p 100000 = 2). Les d&#xE9;fis c est qu il reste encore 17% des districts qui sont silencieux pour la surveillance des PFA et .2 &#xE9;pid&#xE9;mies de rougeole ont connu des ripostes appuy&#xE9;es par l OMS. Aujourdh ui meme si le pays est m&#xFB;r pour une campagne nationale de rougeole, seuls 2 districts sont en &#xE9;pid&#xE9;mie depuis F&#xE9;vrier 2021. l OMS appuie le pays dans l Approvisionnement regulier en reactifs de rougeole.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support surveillance of vaccine-preventable diseases ( AFP, measles, maternal neonatal tetanus, congenital rubella, meningitis, diarrhea rotavirus ...)">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">2 supervisions int&#xE9;gr&#xE9;es ont &#xE9;t&#xE9; r&#xE9;alis&#xE9;es au cours de l ann&#xE9;e 2020 -2021 et ont montr&#xE9; des progr&#xE8;s significatifs dans la surveillance des MEV. L &#xE9;valuation des donn&#xE9;es a montr&#xE9; que les indicateurs de suivi de la surveillance de la rougeole sont de 15, 58 et le taux d &#xE9;ruption non rougeoleuse est de 3, 23 et pour la surveillance des PFA, la proportion de districts ayant atteint les 2 indicateurs de performance (le taux de PFA non polio =2/100000 et une proportion sup &#xE0; 80% d?&#xE9;chantillons ad&#xE9;quats) : 17,02% (8 DS/47)
Taux d?ent&#xE9;rovirus non polio : 7,9% (seuil : &gt;=10%)
et Taux de PFA non Polio = 2,11 p 100000 = 2). Les d&#xE9;fis c est qu il reste encore 17% des districts qui sont silencieux pour la surveillance des PFA et .2 &#xE9;pid&#xE9;mies de rougeole ont connu des ripostes appuy&#xE9;es par l OMS. Aujourdh ui meme si le pays est m&#xFB;r pour une campagne nationale de rougeole, seuls 2 districts sont en &#xE9;pid&#xE9;mie depuis F&#xE9;vrier 2021. l OMS appuie le pays dans l Approvisionnement regulier en reactifs de rougeole.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. The AEFI monitoring system is functional at the operational level ( Health Districit and Health facilities) . At operational level: 1) At least 1 trained provider in each Health Center and Hospital in the country; 2)At least 2 trained provider in each health district management team 3) Reporting tools of the AEFIs are available and used; 4) 100% (47) Health District notify cases of AEFI. 2. The specific tools for pharmacovigilance are produced and disseminated.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MSPLS to strengthen the national pharmacovigilance system and surveillance of AEFI">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Le consultant a &#xE9;t&#xE9; recrut&#xE9; et son chronogramme valid&#xE9; par le comit&#xE9; de pilotage. Le comit&#xE9; technique mis en place est comps&#xE9; de l equipe de l OMS , de IST et du bureau pays pour faire le suivi des travaux. Le comit&#xE9; MAPI est en cours de redynamisation</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) The national pharmacovigilance committee is set up and functional and The first meeting report is available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MSPLS to strengthen the national pharmacovigilance system and surveillance of AEFI">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">le consultant a &#xE9;t&#xE9; recrut&#xE9; et a partag&#xE9; son chrogramme avec le comit&#xE9; de pilotage qui l a valid&#xE9;. La redynamisation du comit&#xE9; de pharmacoviligeance est pr&#xE9;vue d ici la fin du mois de Juin 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MSPLS to strengthen the national pharmacovigilance system and surveillance of AEFI">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">le consultant a &#xE9;t&#xE9; recrut&#xE9; et a partag&#xE9; son chrogramme avec le comit&#xE9; de pilotage qui l a valid&#xE9;. La redynamisation du comit&#xE9; de pharmacoviligeance est pr&#xE9;vue d ici la fin du mois de Juin 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1)100% (47 District) have micro plans, of which 18 are implemented and monitored. the recommendations to find and catch up with the zeros doses are followed. 2) Assessment reports are available. recommendations from data reviews are monitored.3)The multisectoral platform for maternal and child health is extended to all stakeholders.4)At least 80 % of NITAG meeting held and 2 recommandations are implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical Assistant for coverage and equity/Program Implementation for the immunization. EPI support for the next submission of the System strengthening grant;(P4)">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">100%(47districts) disposent de microplans. Les 29 qui restaient ont leurs microplans disponibles Les 18 autres sont en cours de mise en oeuvre.leur &#xE9;valuation d&#xE9;butera en 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Measles campaign report available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the Planning, Implementation and Monitoring of the Measles Vaccination Campaign in Burundi">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Le processus de recrutement du consultant est finalis&#xE9; et la campagnes est pr&#xE9;vue dans la p&#xE9;riode de Octobre &#xE0; D&#xE9;cembre 2021. Le consultant va proc&#xE9;der &#xE0; l elaboration des micro-plans des districts et &#xE0; la planification de la campagne. Le budget a &#xE9;t&#xE9; valid&#xE9; par GAVI mais n est pas encore disponible au Burundi. En attendant nous constatons que le pays est m&#xFB;r pour une campagne et 2 province sont en &#xE9;pid&#xE9;mie (BUBANZA et BUGARAMA). A ce jour le nombe de cas de rougeole &#xE0; la semaine 23 est de 366 et zero d&#xE9;c&#xE8;s.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the Planning, Implementation and Monitoring of the Measles Vaccination Campaign in Burundi">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Le processus de recrutement du consultant est finalis&#xE9; et la campagnes est pr&#xE9;vue dans la p&#xE9;riode de Octobre &#xE0; D&#xE9;cembre 2021. Le consultant va proc&#xE9;der &#xE0; l elaboration des micro-plans des districts et &#xE0; la planification de la campagne. Le budget a &#xE9;t&#xE9; valid&#xE9; par GAVI mais n est pas encore disponible au Burundi. En attendant nous constatons que le pays est m&#xFB;r pour une campagne et 2 province sont en &#xE9;pid&#xE9;mie (BUBANZA et BUGARAMA). A ce jour le nombe de cas de rougeole &#xE0; la semaine 23 est de 366 et zero d&#xE9;c&#xE8;s.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the Planning, Implementation and Monitoring of the Measles Vaccination Campaign in Burundi">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">la campagne rougeole a &#xE9;t&#xE9; repouss&#xE9;e jusqu en D&#xE9;cembre 2021(du 14 au 17 D&#xE9;cembre 2021). cependant l OMS a recrut&#xE9; un consultant qui va soutenir les activit&#xE9;s de micro planification.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">pro-equity micro- plan including zero-dose children approch are implemented in the 18 priorities districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Ensure national coverage in pro-equity micro-plans: support the development of pro-equity micro-plans in 100% health districts and support its implementation. support to the developement, implementation and evaluation of pro-equity-micro plans">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Les activit&#xE9;s inscrites dans les 18 microplans prioritaires prennent en compte l approche zero doses. Leur mise en oeuvre est en cours et fera l objet d &#xE9;valuation en 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) assessment of the implementation of the annual plan (AAP 2020) is carried out and the recommendations integrated into the annual plan 2021-2022 (AAP 2021).2)NITAG members are trained to formulate recommandations for the introduction of new vaccines.3)2 recommendations are submitted to decision makers for the introduction of HB0 and HPV</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical Assistant for coverage and equity/Program Implementation for the immunization. EPI support for the next submission of the System strengthening grant;(P4)">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Un draft des termes de reference du cadre de redevabilit&#xE9; pour la vaccination au niveau communautaire est disponible. La validation est pr&#xE9;vue au courant du semestre prochain.La mise en oeuvre des 18 microplans des districts prioritaires va d&#xE9;marrer le prochain semestre. L&apos;OMS va mobiliser des fonds pour 3 s&#xE9;ances de rattrapage des enfants sous vaccin&#xE9;s et des zero doses.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The Heb0 vaccine is introduced into the routine EPI</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the country in planning, implementing and monitoring the introduction of new vaccines ( Hepatitis at birth_Heb0)">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">le consultant est recrut&#xE9;. Le pays va soumettre &#xE0; la prochaine fen&#xEA;tre pr&#xE9;vue en Septembre 2021 &#xE0; d&#xE9;faut ce sera la 1&#xE8;re fen&#xEA;tre de 2021. Le consultant avec l aval du PEV pourra appuyer l laboration du document de soumission pour l introduction des nouveaux vaccins(HPV et HB0)</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the country in planning, implementing and monitoring the introduction of new vaccines ( Hepatitis at birth_Heb0)">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">le consultant est recrut&#xE9;. Le pays va soumettre &#xE0; la prochaine fen&#xEA;tre pr&#xE9;vue en Septembre 2021 &#xE0; d&#xE9;faut ce sera la 1&#xE8;re fen&#xEA;tre de 2021. Le consultant avec l aval du PEV pourra appuyer l laboration du document de soumission pour l introduction des nouveaux vaccins(HPV et HB0)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.Microplanification of Measles campaign is available in each district. 2. Intra-campaign monitoring coverage surveydone</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the Planning, Implementation and Monitoring of the Measles Vaccination Campaign in Burundi">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">le recrutement du consultant est en cours. Les TDR ont &#xE9;t&#xE9; &#xE9;labor&#xE9;s et publi&#xE9;s. La selection du candidat est fait mais la campagne a &#xE9;t&#xE9; report&#xE9;e jusqu en Octobre 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 80% of the EVM recommendations are implemented. The evaluation implemented report is available.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the EPI for the implementation of the EVM">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Les recommandations de la GEV sont mises en oeuvre par les formations sanitaires. Les proc&#xE9;dures op&#xE9;rationnelles ont &#xE9;t&#xE9; &#xE9;labor&#xE9;es, les gestionnaires et agents de sant&#xE9; ont &#xE9;t&#xE9; form&#xE9;s. Le consultant qui va appuyer l &#xE9;valuation externe de la GEV est &#xE9;galement recrut&#xE9; et le processus suit son cours.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the EPI for the implementation of the EVM">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Les recommandations de la GEV sont mises en oeuvre par les formations sanitaires. Les proc&#xE9;dures op&#xE9;rationnelles ont &#xE9;t&#xE9; &#xE9;labor&#xE9;es, les gestionnaires et agents de sant&#xE9; ont &#xE9;t&#xE9; form&#xE9;s. Le consultant qui va appuyer l &#xE9;valuation externe de la GEV est &#xE9;galement recrut&#xE9; et le processus suit son cours.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The construction/rehabilitation has started (If the funds are available)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Study and carry out an extension / rehabilitation of an EPI storage warehouse">
      <location ref="BI"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Construction works for EPI storage warehouse rehabilitation have not yet started. Fundraising is underway.
The technical assistance expected from UNICEF for this activity is the recruitment of a construction company and the supervision of construction works. The funds for construction are not planned in either the 2020 TCA funds or the 2021 TCA funds. They are planned in the HSS3 additional funds currently under negotiation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least one orientation workshop conducted at national level, with the support of ESARO and Oslo University</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthening of national health information system (HIS),&#xA0; through better quality and use of immunisation data - through BNA, Action Tracker &amp; Scorecards applications for DHIS2">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Instead of a workshop, dur to covid, One Orientation meeting (zoom meeting) were held between ESARO, HISP (OSLO representative) and MoH on the strenghning of HIS through the DHIS2 support.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">* Number of Community Health worker Trained on the monitoring of pregnant and child (including the vaccination)&#xA0;in the community and register them in Rapidms system * At Least one person in every health facility is able to enter data&#xA0;in the Rapidsms data</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Extend the SMSRapid project on monitoring the child / one thousand days, including the recovery of irregular / abandoned in the 18 priority DS">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Same comments for Nonvember 2020 report: Funds for the training of CHWs of the 18 HDs on RapidSMS for vaccination are not yet available. However, with UNICEF funds, 1410 CHWs of the 6 HD in two provinces (Gitega and Cankuzo) are already using this RapidSMS technology for recalling and catching up children for immunization in these HD.
The 6 HD are not included in the 18 HD initially planned.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The report of the consultance is available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Exploring the possibility of a performance bonus for the DS on coverage and equity (AT) / Including the PBF approach">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The activity has been finalized and the report is available. The report was shared with Gavi.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">ToRs for the activity are finalized and the partnership with OSLO University concluded</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen national capacities on DHIS2 Management at all levels and initiate the interoperability with other existing databases by involving the partnership between GAVI Alliance and the University of Oslo">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">ToR are finalized and partnership with OSLO concluded. HISP are providing support to complete the interoperability with other Database.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">DHIS2 and RapiSMS interoparability is functional in at least 4 DS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue to support the MoH/EPI to strengthen national capacities on DHIS2 Management at all levels and initiate the interoperability with other existing databases by involving the partnership between GAVI Alliance and the University of Oslo">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Interoperbility work is ongoing between DHIS2 and Two RapidPro based applications which are the iCCM inputs management application and the Mother and Child monitoring application.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Quarterly triangulation analysis of immunization data performed and feedback sent to HD</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MoH/ EPI for triangulation analysis of immunization data (coverage, vaccine consumption, vaccine wastage rates, surveillance, etc). WHO is the lead for this activity and UNICEF is contributing.">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The activity is ongoing.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Electronic Immunisation Registry Design</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Cintinue to support the MoH (DSNIS &amp; EPI) to develop and implement an Electronic Registry for immunization">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The assessment of national capacities for the introduction of the REI is underway; the report will be available by the end of December 2021 and a roadmap will be established.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Readiness assessment implemented, Roadmap available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Cintinue to support the MoH (DSNIS &amp; EPI) to develop and implement an Electronic Registry for immunization">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The assessment of national capacities for the introduction of the REI is underway; the report will be available by the end of December 2021 and a roadmap will be established.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Cintinue to support the MoH (DSNIS &amp; EPI) to develop and implement an Electronic Registry for immunization">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">This milestones is related to the implementation of Electronic Registry for Immunization. Due to Covid-19 these activity was delayed but now, with UNICEF support, the EPI prepare the readiness assessment which is planned for the third quarter of this year 2021 with support from RO. Next step will be to implement a pilot project of electronic register in some health districts.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least three new health district offices/warehouse constructed/rehabilitated and handed over to MoH</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical supports for the implementation of immunization activities (Supply, Finances and construction&quot;)">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The construction of offices and stocks of 2 health districts is finalized. The provisional acceptance of the works took place in May 2021. The construction of the 3rd district will be finalized soon, its reception is scheduled for July 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical supports for the implementation of immunization activities (Supply, Finances and construction&quot;)">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The construction of offices and stocks of 2 health districts is finalized. The provisional acceptance of the works took place in May 2021. The construction of the 3rd district will be finalized soon, its reception is scheduled for July 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunisation-related planning priorities and resource needs reflected in the national health plan and budget/medium-term expenditure frameworks</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the country to implement the Immunization Resource Mobilization Strategy">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The financing of vaccines has been given priority in the Government&apos;s budget for 2021-2022. The 2021 co-financing and traditional vaccine funds have already been disbursed and transferred to UNICEF Supply Division.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 20 additional public and private centers and clinics offering immunization services</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the EPI for the establishment of a public-private partnership roadmap in the provision of immunization services: Private partners mapping and their areas of services, advocacy and engagement">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The mapping of health facilities with vaccination services in the three health districts of the Bujumbura city has been finalized. The identification of health facilities to be accredited for vaccination services in Bujumbura city has been made and discussed with the EPI manager. An advocacy workshop with these private structures is planned at the beginning of July 2021 to get their commitment to offer immunization services.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the EPI for the establishment of a public-private partnership roadmap in the provision of immunization services: Private partners mapping and their areas of services, advocacy and engagement">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The mapping of health facilities with vaccination services in the three health districts of the Bujumbura city has been finalized. The identification of health facilities to be accredited for vaccination services in Bujumbura city has been made and discussed with the EPI manager. An advocacy workshop with these private structures is planned at the beginning of July 2021 to get their commitment to offer immunization services.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A geo-localised list of all health facilities (Public, private) exists, and at least two sessions of advocacy, social mobilization for Private partners in Bujumbura capital are done to advanced the expansion plan.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the EPI for the establishment of a public-private partnership roadmap in the provision of immunization services: Private partners mapping and their areas of services, advocacy and engagement">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The mapping of health facilities with vaccination services in the three health districts of the Bujumbura city has been finalized. The identification of health facilities to be accredited to offer vaccination services in Bujumbura city has been made and discussed with the EPI manager. An advocacy workshop with these private structures is planned at the beginning of July 2021 to get their commitment to offer immunization services.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">National Immunization Policy and Immunization Law Adopted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the country in implementing the Immunization Resource Mobilization Strategy">
      <location ref="BI"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">This activity was delayed due to Covid-19. The country was unable to have an international consultant for this activity.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the country in implementing the Immunization Resource Mobilization Strategy">
      <location ref="BI"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">This activity was delayed due to Covid-19. The country was unable to have an international consultant for this activity.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the country in implementing the Immunization Resource Mobilization Strategy">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A special allocation budget (mother and child health fund) is established in the general state budget to further mobilize public resources for immunization</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the country in implementing the Immunization Resource Mobilization Strategy">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF continues to support the MoH for advocacy so that the Government can increase the budget of two budget lines for vaccines. Thus, a workshop to disseminate the strategy for mobilizing internal funds for immunization and advocate for its implementation was organized in January 2021. As result for this year, the Government budget for vaccines has been increased: the co-financing line has been multiplied by 2.5, from 800,000,000 BIF to 2,000,000,000 BIF and the line for traditional vaccines has been multiplied by 4, from 50,000,000 BIF to 200,000,000 BIF.
UNICEF continue its support to establish a special fund for financing mother and child health; advocacy continues.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Proposals for HPV and for Heb0 introduction are submitted to Gavi on time</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the country in planning, implementing and monitoring the introduction of new vaccines / new doses (Td5, Td6, HPV, Heb0) (social mobilization, cold chain and logistics component)">
      <location ref="BI"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Due to Covid-19, the activity was delayed. The submission to Gavi for the introduction of these new vaccines is not done. It is scheduled for the 3rd quarter of 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A social mobilization plan and a logistic plan for HPV and for Heb0 introduction are available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the country in planning, implementing and monitoring the introduction of new vaccines / new doses (Td5, Td6, HPV, Heb0) (social mobilization, cold chain and logistics component)">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The introduction of the new vaccines/doses are postponed</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the country in planning, implementing and monitoring the introduction of new vaccines / new doses (Td5, Td6, HPV, Heb0) (social mobilization, cold chain and logistics component)">
      <location ref="BI"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The introduction of these new vaccines is not effective. The submission to Gavi for the introduction of these vaccines is scheduled for the 3rd quarter of 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the country in planning, implementing and monitoring the introduction of new vaccines / new doses (Td5, Td6, HPV, Heb0) (social mobilization, cold chain and logistics component)">
      <location ref="BI"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The introduction of these new vaccines is not effective. The submission to Gavi for the introduction of these vaccines is scheduled for the 3rd quarter of 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The measles vaccination campaign has been conducted successfully: 95 % of target population are vaccinated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the planning, implementation and monitoring of the measles vaccination campaign in Burundi (social mobilization, cold chain and logistics component)">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The MR campaign is planned for December 2021, UNICEF support its preparation specifically for social mobilization, cold chain and logistics.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the planning, implementation and monitoring of the measles vaccination campaign in Burundi (social mobilization, cold chain and logistics component)">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The measles and rubella campaign has not yet been completed. Funds are not yet available. UNICEF and WHO supported the MoH/EPI in developing and submitting the proposal to Gavi for this follow-up campaign. The proposal has been reviewed and approved by IRC but the budget is still being negotiated between Gavi and MoH/EPI. This campaign is rescheduled for the 4th quarter of 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the planning, implementation and monitoring of the measles vaccination campaign in Burundi (social mobilization, cold chain and logistics component)">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The measles and rubella campaign has not yet been completed. Funds are not yet available. UNICEF and WHO supported the MoH/EPI in developing and submitting the proposal to Gavi for this follow-up campaign. The proposal has been reviewed and approved by IRC but the budget is still being negotiated between Gavi and MoH/EPI. This campaign is rescheduled for the 4th quarter of 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Vaccine application documents/plans developed, completed and submitted in a timely manner</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MoH/EPI to timely prepare, finalize and submit vaccine request documents / plans (Request for renewal of vaccines, introduction of Heb0, introduction of HPV, etc.)">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The proposals for the introduction of HPV and Heb0 are ongoing. The proposal for the introduction of HPV will be submitted in January 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">An evaluation of waste management at the operational level is carried out and the report available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue to support the MoH/ EPI to strengthen the management of vaccine waste at all levels">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Activity completed with the inventory of the cold chain equipment. The report is available</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of district vaccine managers trained on vaccine management</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MoH/EPI for the implementation of standard operating procedures on vaccine management at all levels ( Inventory of cold chain equipment at all levels, training of vaccine managers et district level)">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">All pharmacies managers / HD vaccine managers have been trained on the new SOPs.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 50% of DS technicians have been trained in solar equipment maintenance.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Continue to support MoH/ EPI to implement the cold chain equipment maintenance strategic plan for all levels (post installation follow up and monitoring of solar refrigerators newly installed, training of technicians at district level in solar equipment maintenance.)">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">At least one maintenance technician per HD has been trained</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">RTMD for HD are identified, specified and ordered</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support MoH/ PEV for installation of continuous monitoring system of temperature of the cold chain equipment at central and district levels">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Funds for the purchase of equipment are not yet available. However, a pilot phase will be conducted in 25 storage depots from December and the manufacturer has already sent the devices.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The TORs for the recruitment of the design office are finalized and validated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the rehabilitation/construction of offices and stocks of Health Districts and the rehabilitation of the roofs of health centers">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The activity is completed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Inventory report is available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MoH/EPI for the implementation of standard operating procedures on vaccine management at all levels ( Inventory of cold chain equipment at all levels, training of vaccine managers et district level)">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The cold chain inventory has been conducted in April 2021 . The preliminary report is available. Its validation and finalization are scheduled for July 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The final designs are available and the recruitment of a construction company is finalized</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the rehabilitation/construction of offices and stocks of Health Districts and the rehabilitation of the roofs of health centers">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">The rehabilitation / construction of offices and stocks of the three Health Districts has been finalized. The rehabilitation of the roofs of health centers has not yet been carried out for lack of funds.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">an accountability framework to improve immunization performance and zero-dose children approach is put in place in the 18 priority districts</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the establishment and operation of a multisectorial accountability framework (community leaders, administrative leaders, other development sectors) to improve immunization performance in the 18 priority districts">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Un draft du cadre de redevabilit&#xE9; de la vaccination au niveau communautaire est en cours d&apos;&#xE9;laboration suite &#xE0; une collecte de donn&#xE9;es et une analyse situationnelle . La validation est pr&#xE9;vue en Fin Novembre et la mise en oeuvre &#xE0; partir de Janvier 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">World Bank : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) draft of efficiency study available and presented to Government and 2) dialogue on immunization financing facilitated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Year 1 focused on analytics with the fiscal space assessment and immunization financing assessment. In 2020, the team will continue providing support around the recommendations coming out of the analytics, which includes: improving quality of public spending for PHC; improving transparency of budget formulation and execution, and improve predictability of expenditure; maintaining the high prioritization on health, while exploring opportunities to raise sector-specific taxes through the use of taxes ?win-win-win? taxes, for example cigarettes and sugary drinks etc. One specific recommendation from the report is to reassess the tarriffs paid by the RBF project to ensure financial sustainability and to incentivize full immunization coverage. Support to the World Bank will also cover the development of the health financing strategy including further analytics, as well as continuous dialogue around PFM.">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Dialogue on vaccine financing completed on June 24, 2021. Dialogue on health financing strategy in progress together with other development partners. Dialogue led by the WB as part of P4H process led to GoB official request for a P4H focal point based in Burundi and who will support the development of the health financing strategy.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Year 1 focused on analytics with the fiscal space assessment and immunization financing assessment. In 2020, the team will continue providing support around the recommendations coming out of the analytics, which includes: improving quality of public spending for PHC; improving transparency of budget formulation and execution, and improve predictability of expenditure; maintaining the high prioritization on health, while exploring opportunities to raise sector-specific taxes through the use of taxes ?win-win-win? taxes, for example cigarettes and sugary drinks etc. One specific recommendation from the report is to reassess the tarriffs paid by the RBF project to ensure financial sustainability and to incentivize full immunization coverage. Support to the World Bank will also cover the development of the health financing strategy including further analytics, as well as continuous dialogue around PFM.">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Dialogue on vaccine financing completed on June 24, 2021. Dialogue on health financing strategy in progress together with other development partners. Dialogue led by the WB as part of P4H process led to GoB official request for a P4H focal point based in Burundi and who will support the development of the health financing strategy.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">First phase of analytical work to inform health financing strategy disseminated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Year 1 focused on analytics with the fiscal space assessment and immunization financing assessment. In 2020, the team will continue providing support around the recommendations coming out of the analytics, which includes: improving quality of public spending for PHC; improving transparency of budget formulation and execution, and improve predictability of expenditure; maintaining the high prioritization on health, while exploring opportunities to raise sector-specific taxes through the use of taxes ?win-win-win? taxes, for example cigarettes and sugary drinks etc. One specific recommendation from the report is to reassess the tarriffs paid by the RBF project to ensure financial sustainability and to incentivize full immunization coverage. Support to the World Bank will also cover the development of the health financing strategy including further analytics, as well as continuous dialogue around PFM.">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Efficiency study in progress. Dialogue on health financing strategy in progress together with other development partners. Dialogue led by the WB as part of P4H process led to GoB official request for a P4H focal point based in Burundi and who will support the development of the health financing strategy.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Analysis/dialogue on domestic financing options for immunisation and health conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="The request for TCA support focuses on providing technical assistance and supporting policy dialogue to develop a new health financing strategy. This activity will build on previous TCA (fiscal space assessment, immunization financing assessment, on-going efficiency study and dialogue on vaccine financing). Studies highlighted that Burundi faces many challenges in mobilizing adequate domestic resources for health and ensuring those resources are allocated in an efficient and predictable manner to allow the delivery of high-quality primary health services, including immunization. For the coming year, WB TA activities will focus on drafting a situation analysis of health financing (revenue collection, resource pooling and purchasing) and producing practical key documents to support policy dialogue to develop the strategy, while prioritizing primary health care and immunization services. 
The purpose of this work is to support the development and implementation of a sustainable health financing strategy. It will continue the work and dialogue started on health financing in Burundi. This activity also has synergies with the WB project called KIRA supporting the PBF program with a planned additional financing in 2021, including a Gavi HSS grant cofinancing the project. 
The WB team will continue working with EPI/UGP and CTN FBP to help making links with the development of the new health financing strategy, focusing on equity issues to reach zero-dose children and reflecting changes in the PBF program indicators to align with this approach.">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Various analytical pieces are under way to support the development of the national Health financing strategy, expected by March 2022: an efficiency study is in progress with draft slides available and a discussion paper is being developed to explore sustainability of PBF. Finally, the situation analysis of health financing is being finalized by the P4H focal point with resources mobilized by P4H through FRANCE Cooperation. The Bank team has provided inputs and participated in the validation workshop of the analysis. In coordination with other development partners, the dialogue on health financing strategy is making progress towards the development of the strategy.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Terms of reference for recruitment are published and consultant hired within 3 months</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MoH/EPI for updating the EVM improvement plan and its implementation and monitoring">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Le consutant international a &#xE9;t&#xE9; recrut&#xE9; et a d&#xE9;marr&#xE9; son travail avec le niveau national.un comit&#xE9; technique de suivi compos&#xE9; du staff OMS du bureau pays et de l IST aaest mis en place pour le suivi des travaux du consultant. Son chronogramme de travail est &#xE9;tabli et a &#xE9;t&#xE9; valid&#xE9; par le comit&#xE9; de pilotage</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EVM evaluation completed and sumitted to MOH including analysis of VFM and zero dose considerations</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MoH/EPI for updating the EVM improvement plan and its implementation and monitoring">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">la GEV a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e et des recommandations formul&#xE9;es &#xE0; l&apos;endroit de tous les acteurs pour am&#xE9;liorer la gestion des vaccins. Le plan d&apos;am&#xE9;lioration sera r&#xE9;alis&#xE9;e au premier trimestre de 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Human Resources for Health</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">the modules are developed and available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MSPLS to update courses on maternal and child health including EPI in the curricula for training of paramedical schools, institutes of public health, and universities">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Le recrutement du consultant est en cours de finalisation. la s&#xE9;l&#xE9;ction des candidats a &#xE9;t&#xE9; faite. Il reste la s&#xE9;l&#xE9;ction du candidat retenu.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">a pool of trainers is set up and operational to ensure the training of health establishments on the new training curriculum including the EPI is implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MSPLS to update courses on maternal and child health including EPI in the curricula for training of paramedical schools, institutes of public health, and universities">
      <location ref="BI"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">la requ&#xEA;te du minist&#xE8;re a &#xE9;t&#xE9; re&#xE7;ue et le recrutement du consultant est en cours</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The validate guide update is available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to Update the standard SNIS data analysis guide (need for technical assistance) and dissemination">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Le draft de guide est disponible et valid&#xE9; par le minist&#xE8;re de la sant&#xE9;. Le consultant est entrain d integrer tous les commentaires avant de partager le guide finalis&#xE9; pour la validation strat&#xE9;gique et la diss&#xE9;mination . un atelier de validation et de consensus a &#xE9;t&#xE9; realis&#xE9; du 21 au 25 Juin 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The report of the consultance is available and the guide disseminate</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support to Update the standard SNIS data analysis guide (need for technical assistance) and dissemination">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Le guide SNIS est disponible. Sa validation est pr&#xE9;vue la semaine du 21 Juin2021. La prochaine &#xE9;tape sera sa diss&#xE9;mination aupr&#xE8;s de tous les acteurs et des partenaires techniques et financiers.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training curricula in the paramedical schools, institutes of public health and university updated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for the updating of training curricula in the paramedical schools, institutes of public health and university (Faculties of Medicine): Immunization modules / courses">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Lrecrutement du consultant est en cours de finalisation. La s&#xE9;l&#xE9;ction des candidats est fait. Il reste la selection du candidat retenu.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Regional AT and consultant available : 1.Technical Advisory Group on Immunization (NITAG) is functional 2. Number of subjects on immunization treated by the NITAG</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for the establishment of the NITAG and monitoring of its operation">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">le NITAG a re&#xE7;u 3 sessions d orientation avec l appui des experts de AFRO. durant ces sessions, les documents de fonctionnement ont &#xE9;t&#xE9; produits et valid&#xE9;s et 2 recommandations ont &#xE9;t&#xE9; formul&#xE9;s par le NITAG sous forme d exercices</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunization modules /courses elaborate and disseminated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for the updating of training curricula in the paramedical schools, institutes of public health and university (Faculties of Medicine): Immunization modules / courses">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">le recrutement du consultant internationa est en cours de finalisation. Les TDR ont &#xE9;t&#xE9; publi&#xE9;s, la selectiondes canidats eligibles faite. Rest e&#xE0; selectionn&#xE9; le candidat retenu et de demarrer les travaux</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) Availability of guidelines at 100% of supervised health centers. 2) At least 95% of supervised health centers apply the guidelines correctly.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the EPI for the development of the Technical Guide">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Un draft du guide technique est disponible. Le consultant a &#xE9;t&#xE9; recrut&#xE9; et va proc&#xE9;der &#xE0; la finalisation du guide d ici fin juillet 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the EPI for the development of the Technical Guide">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Un draft du guide technique est disponible. Le consultant a &#xE9;t&#xE9; recrut&#xE9; et va proc&#xE9;der &#xE0; la finalisation du guide d ici fin juillet 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The manual ( technical guide) is validated, then disseminated at all levels</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the EPI for the development of the Technical Guide">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">le processus de recutement du consultant est en cours de finalisation. La s&#xE9;lection est effectu&#xE9;e et le consulta a &#xE9;t&#xE9; notifi&#xE9;. Undraft de guide existe et fera l objet de validation avec l appui du consultant d ici juillet 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The training modules to be included in the curricula training of paramedical schools, public health institutes and universities on the health of mother and child is available and shared.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MSPLS to update courses on maternal and child health in the curricula for training of paramedical schools, institutes of public health, and universities">
      <location ref="BI"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">le recrutement du consultant est en cours. Les modules ne sont pas encore &#xE9;labor&#xE9;s</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MSPLS to update courses on maternal and child health in the curricula for training of paramedical schools, institutes of public health, and universities">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">les modules de formation ne sont pas encore inclus dans le curricula de formation des &#xE9;coles et etablissements de sant&#xE9;. le consultant a &#xE9;t&#xE9; recrut&#xE9; .ses travaux vont d&#xE9;marrer &#xE0; partir de juillet 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MSPLS to update courses on maternal and child health in the curricula for training of paramedical schools, institutes of public health, and universities">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">les modules de formation ne sont pas encore inclus dans le curricula de formation des &#xE9;coles et etablissements de sant&#xE9;. le consultant a &#xE9;t&#xE9; recrut&#xE9; .ses travaux vont d&#xE9;marrer &#xE0; partir de juillet 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Theoverall preliminary project of updating the training curricula of the paramedical schools, the institutes of public health and the universities on the health of the mother and the child is available and shared.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MSPLS to update courses on maternal and child health in the curricula for training of paramedical schools, institutes of public health, and universities">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">les modules ne sont pas encore &#xE9;labor&#xE9;s car le processus du recrutement du consultant international est en cours</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1)the district focal points are trained 2)The committee of experts for AEFI surveillance is functional</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MSPLS to strengthen the national pharmacovigilance system and surveillance of AEFI">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">198 participants du niveau central, des BPS, des h&#xF4;pitaux nationaux et centres de prise en charge sp&#xE9;cialis&#xE9;s et des districts sanitaires ont &#xE9;t&#xE9; form&#xE9;s sur la notification et l?investigation des MAPI/EIM lors d?un atelier de deux jours qui a &#xE9;t&#xE9; tenu entre Juin et Juillet 2021.Le comit&#xE9; des experts MAP a &#xE9;t&#xE9; orient&#xE9; sur l&apos;analyse causale des MAPI. une 1ere r&#xE9;union du comit&#xE9; a &#xE9;t&#xE9; tenue pour nettoyer la base ODK Collect t&#xE9;moignant de la fonctionalit&#xE9; du comit&#xE9;.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1)New specific VPD surveillance system( sentinel surveillance site for measles, congenital rubella syndrome, menigitis and diarrhea)implemented and data monthly monitored</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support surveillance of vaccine-preventable diseases ( AFP, measles, maternal neonatal tetanus, congenital rubella, meningitis, diarrhea rotavirus ...)">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">3 sites sentinelles ont &#xE9;t&#xE9; mis en place depuis D&#xE9;cembre 2021. Le principal site qui est le CHU Kamengue est fonctionnel pour la surveillance de toutes les formes de m&#xE9;ningites. le d&#xE9;fi reste la disponibilit&#xE9; des &#xE9;quipements et des intrants pour faciliter la surveillance des diarrh&#xE9;es sous toutes ses formes et du syndrome de rubeole cong&#xE9;nitale. une supervision a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e en Mars 2021 pour faire le suivi des notifications, de collecte des &#xE9;chantillons et de collecte des donn&#xE9;es.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Updated pharmacovigilance tools are available in all health facilities (FOSA)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MSPLS to strengthen the national pharmacovigilance system and surveillance of AEFI">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Le consultant a &#xE9;t&#xE9; recrut&#xE9;. Son chrongramme est valid&#xE9; par le comit&#xE9; de pilotage. La redynamisation du comit&#xE9; technique est en cours. les outils de pharmacovigilance sont disponibles et valid&#xE9;s .Une formation des prestataires du niveau p&#xE9;riph&#xE9;rique est pr&#xE9;vue d ici les mois de Juin et juillet 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Terms of reference for recruitment are published and consultant hired within 3 months</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MOH/EPI to improve the quality of data">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">le draft des termes de r&#xE9;ference a &#xE9;t&#xE9; &#xE9;labor&#xE9; . La validation est en cours avant de passer &#xE0; la publication.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1)In-depth assessment of data quality (DQR, DQA, audit)2 ) the data quality improvement plan is reviewed and implemented.2)Data desk review or triangulation analysis performed 
(coverage, surveillance, operational)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the MOH/EPI to improve the quality of data">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">le recrutement du consultant est en cours en collaboration avec AFO/IST pour un consultant international. n&#xE9;anmoins La triangulation des donn&#xE9;es est effectu&#xE9;e tous les 3 mois au niveau des districts avec le support technique de l&apos;OMS (Stop team) et des recommandations sont formul&#xE9;es pour am&#xE9;liorer le collecte et l&apos;analyse des donn&#xE9;es. Cette triangulation est compl&#xE9;t&#xE9;e par une revue semestrielle pour une revue de la mise en oeuvre des recommandations.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The surveillance indicators of vaccine-preventable diseases in all 47 Health Districts (100%) are monitored each month and written feedback is made</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support surveillance of vaccine-preventable diseases ( AFP, measles, maternal neonatal tetanus, congenital rubella, meningitis, diarrhea rotavirus ...)">
      <location ref="BI"></location>
     </target>
     <actual value="Completed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">un SITREP de surveillance des indicateurs de la poliomyelite et de la rougeole est &#xE9;labor&#xE9; par le PEV en collaboration avec l&apos;OMS chaque semaine puis partag&#xE9; jusque&apos; au niveau district et des s&#xE9;ances de partage des donn&#xE9;es mensuelles est effectu&#xE9; au sein des districts sanitaires</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) AAP 2020 implementation evaluated and recommendations for improvement integrated into AAP 2021. 2) PAA 2021 available. 3) 100% (47 Health Districts ) of Micro plans reviews and recommendations made to improve quality. 4) 100% of the DS receiving coaching have RR2 CV&gt; 80%</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical Assistant for coverage and equity/Program Implementation for the immunization (P4)">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">le staff international poursuit son appui au programme elargi de vaccination pour renforcer l equite dans la vaccination et ameliorer les couvertures vaccinales. La chute des couvertures entre 2020 et 2021 pour les memes periodes sont li&#xE9;es au contexte de COVID 19 et &#xE0; la population cible qui a augment&#xE9; selon ls projections de l ISTEBU. Le staff international planifie avec l appui du niveau r&#xE9;gional de faire des s&#xE9;ances de rattrapage des enfants sous vaccin&#xE9;s ou zero doses entre juillet et septembre 2021. avec la redynamisation du partenariat du groupe H6 du syst&#xE8;me des Nations Unies, Le Groupe Th&#xE9;matique Sant&#xE9; m&#xE8;re enfant s est &#xE9;largi aux partenaires techniques et financiers . Les termes de r&#xE9;f&#xE9;rence seront revus pour renforcer la particpation de la soci&#xE9;t&#xE9; civile et des associations des acad&#xE9;miciens et universitaires. La fonctionalit&#xE9; de ce groupe a permis d organiser des visites conjointes MSPLS et partenaires techniques et financiers sur le maintien des services essentiels de sant&#xE9; et des recommandations sont formul&#xE9;es aux districts sanitaires en vue de l am&#xE9;lioration des couvertures. Les termes de r&#xE9;f&#xE9;rence du cadre de redevabilit&#xE9; pour la vaccination sont en cours d&apos;&#xE9;laboration et seront valid&#xE9;s d&apos; ici le 30 Juin 2021.la disponibilit&#xE9; des fonds additionnels RSSIII permettra de d&#xE9;marrer la mise en oeuvre des micro-plans pro-&#xE9;quit&#xE9; au niveau des districts prioritaires.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical Assistant for coverage and equity/Program Implementation for the immunization (P4)">
      <location ref="BI"></location>
     </target>
     <actual value="On Track">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">le staff international poursuit son appui au programme elargi de vaccination pour renforcer l equite dans la vaccination et ameliorer les couvertures vaccinales. La chute des couvertures entre 2020 et 2021 pour les memes periodes sont li&#xE9;es au contexte de COVID 19 et &#xE0; la population cible qui a augment&#xE9; selon ls projections de l ISTEBU. Le staff international planifie avec l appui du niveau r&#xE9;gional de faire des s&#xE9;ances de rattrapage des enfants sous vaccin&#xE9;s ou zero doses entre juillet et septembre 2021. avec la redynamisation du partenariat du groupe H6 du syst&#xE8;me des Nations Unies, Le Groupe Th&#xE9;matique Sant&#xE9; m&#xE8;re enfant s est &#xE9;largi aux partenaires techniques et financiers . Les termes de r&#xE9;f&#xE9;rence seront revus pour renforcer la particpation de la soci&#xE9;t&#xE9; civile et des associations des acad&#xE9;miciens et universitaires. La fonctionalit&#xE9; de ce groupe a permis d organiser des visites conjointes MSPLS et partenaires techniques et financiers sur le maintien des services essentiels de sant&#xE9; et des recommandations sont formul&#xE9;es aux districts sanitaires en vue de l am&#xE9;lioration des couvertures. Les termes de r&#xE9;f&#xE9;rence du cadre de redevabilit&#xE9; pour la vaccination sont en cours d&apos;&#xE9;laboration et seront valid&#xE9;s d&apos; ici le 30 Juin 2021.la disponibilit&#xE9; des fonds additionnels RSSIII permettra de d&#xE9;marrer la mise en oeuvre des micro-plans pro-&#xE9;quit&#xE9; au niveau des districts prioritaires.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of the priority health districts have an RR2 CV&gt; 80%.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Ensure national coverage in pro-equity micro-plans: support the development of pro-equity micro-plans in 100% health districts and support its implementation">
      <location ref="BI"></location>
     </target>
     <actual value="Major Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Les couverture en RR2 est de 76, 9% au mois de septembre . L objectif n est pas atteint et peut &#xEA;tre imput&#xE9; aux difficult&#xE9;s d acc&#xE8;s aux services de vaccination li&#xE9;s en partie au contexte de COVID 19 et une insuffisance dans la communication et les strat&#xE9;gies de rattrapage des enfants sous vaccin&#xE9;s. L ISTEBU a &#xE9;galement surestim&#xE9; les cibles de la vaccination cette ann&#xE9;e ce qui a r&#xE9;duit consid&#xE9;rablement toutes les couvertures.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Ensure national coverage in pro-equity micro-plans: support the development of pro-equity micro-plans in 100% health districts and support its implementation">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">seuls 18 districts ont d&#xE9;velopp&#xE9; des micro-plans. Il est pr&#xE9;vu de d&#xE9;velopper les microplans des 29 districts qui restent et de mettre en oeuvre les 18 micro-plans. En 2020, La couverture vaccinale moyenne au RR1 est de 89,4%, seuls 16/47 districts sanitaires ont une cou-verture vaccinale &lt; &#xE0; 80% (soit 34.04%).</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Ensure national coverage in pro-equity micro-plans: support the development of pro-equity micro-plans in 100% health districts and support its implementation">
      <location ref="BI"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">seuls 18 districts ont d&#xE9;velopp&#xE9; des micro-plans. Il est pr&#xE9;vu de d&#xE9;velopper les microplans des 29 districts qui restent et de mettre en oeuvre les 18 micro-plans. En 2020, La couverture vaccinale moyenne au RR1 est de 89,4%, seuls 16/47 districts sanitaires ont une cou-verture vaccinale &lt; &#xE0; 80% (soit 34.04%).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunisation registry digital package configured and installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of immunisation registries">
      <location ref="BI"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Adjusted work plan upon discussion sent to the country for validation</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3. EPI legacy data migrated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="BI"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="BI"></location>
      <comment>
       <narrative xml:lang="EN">Adjusted work plan upon discussion sent to the country for validation</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on planned digital data package or app and know how to use it
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="BI"></location>
     </target>
     <actual>
      <location ref="BI"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunisation registry piloted in one district.
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of immunisation registries">
      <location ref="BI"></location>
     </target>
     <actual>
      <location ref="BI"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Transition plan for EPI in place with agreed date for end of parallel system
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="BI"></location>
     </target>
     <actual>
      <location ref="BI"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
